Correlation Between Artivion and Guided Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Artivion and Guided Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Artivion and Guided Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Artivion and Guided Therapeutics, you can compare the effects of market volatilities on Artivion and Guided Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Artivion with a short position of Guided Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Artivion and Guided Therapeutics.

Diversification Opportunities for Artivion and Guided Therapeutics

0.33
  Correlation Coefficient

Weak diversification

The 3 months correlation between Artivion and Guided is 0.33. Overlapping area represents the amount of risk that can be diversified away by holding Artivion and Guided Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Guided Therapeutics and Artivion is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Artivion are associated (or correlated) with Guided Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Guided Therapeutics has no effect on the direction of Artivion i.e., Artivion and Guided Therapeutics go up and down completely randomly.

Pair Corralation between Artivion and Guided Therapeutics

Given the investment horizon of 90 days Artivion is expected to generate 0.15 times more return on investment than Guided Therapeutics. However, Artivion is 6.76 times less risky than Guided Therapeutics. It trades about 0.1 of its potential returns per unit of risk. Guided Therapeutics is currently generating about 0.01 per unit of risk. If you would invest  2,887  in Artivion on September 12, 2024 and sell it today you would earn a total of  96.00  from holding Artivion or generate 3.33% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Artivion  vs.  Guided Therapeutics

 Performance 
       Timeline  
Artivion 

Risk-Adjusted Performance

14 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Artivion are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively conflicting basic indicators, Artivion unveiled solid returns over the last few months and may actually be approaching a breakup point.
Guided Therapeutics 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Guided Therapeutics are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Even with relatively inconsistent technical indicators, Guided Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.

Artivion and Guided Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Artivion and Guided Therapeutics

The main advantage of trading using opposite Artivion and Guided Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Artivion position performs unexpectedly, Guided Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Guided Therapeutics will offset losses from the drop in Guided Therapeutics' long position.
The idea behind Artivion and Guided Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.

Other Complementary Tools

Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Money Managers
Screen money managers from public funds and ETFs managed around the world
Stocks Directory
Find actively traded stocks across global markets